Comparison

LY2090314 European Partner

Item no. TMO-T1755-1ml
Manufacturer TargetMol
CASRN 603288-22-8
Amount 1 mL
Quantity options 100 mg 1 mL x 10 mM (in DMSO) 10 mg 1 mg 1 mL 25 mg 2 mg 50 mg 5 mg
Category
Type Chemicals
Specific against other
Smiles Fc1cc2CN(CCn3cc(C4=C(C(=O)NC4=O)c4cnc5ccccn45)c(c1)c23)C(=O)N1CCCCC1
ECLASS 10.1 32160000
ECLASS 11.0 32160000
UNSPSC 12000000
Alias GSK-3,GSK-3
Similar products 603288-22-8
Shipping Condition Cool pack
Available
Manufacturer - Targets
GSK-3
Shipping Temperature
Cool pack
Storage Conditions
-20
Molecular Weight
512.53
Description
LY2090314, an effective GSK-3α/β inhibitor (IC50: 1.5 nM/0.9 nM), may improve the efficacy of platinum-based chemotherapy regimens. LY2090314 has been used in trials studying the treatment of Leukemia, Advanced Cancer, and Pancreatic Cancer.
Pathways
PI3K/Akt/mTOR signaling|||Stem Cells

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 1 mL
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close